These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8306751

  • 1. Inhaled ICI 204,219 blocks antigen-induced bronchoconstriction in subjects with bronchial asthma.
    Nathan RA, Glass M, Minkwitz MC.
    Chest; 1994 Feb; 105(2):483-8. PubMed ID: 8306751
    [Abstract] [Full Text] [Related]

  • 2. Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction.
    O'Shaughnessy KM, Taylor IK, O'Connor B, O'Connell F, Thomson H, Dollery CT.
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1431-5. PubMed ID: 8389105
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.
    Smith LJ, Glass M, Minkwitz MC.
    Clin Pharmacol Ther; 1993 Oct; 54(4):430-6. PubMed ID: 8222486
    [Abstract] [Full Text] [Related]

  • 4. Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma.
    Findlay SR, Barden JM, Easley CB, Glass M.
    J Allergy Clin Immunol; 1992 May; 89(5):1040-5. PubMed ID: 1583246
    [Abstract] [Full Text] [Related]

  • 5. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects.
    Taylor IK, O'Shaughnessy KM, Fuller RW, Dollery CT.
    Lancet; 1991 Mar 23; 337(8743):690-4. PubMed ID: 1672176
    [Abstract] [Full Text] [Related]

  • 6. The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics.
    Dahlén B, Zetterström O, Björck T, Dahlén SE.
    Eur Respir J; 1994 Feb 23; 7(2):324-31. PubMed ID: 8162986
    [Abstract] [Full Text] [Related]

  • 7. The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma.
    Makker HK, Lau LC, Thomson HW, Binks SM, Holgate ST.
    Am Rev Respir Dis; 1993 Jun 23; 147(6 Pt 1):1413-8. PubMed ID: 8389103
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reversion of methacholine induced bronchoconstriction with inhaled diazepam in patients with asthma.
    Miric M, Ristic S, Joksimovic BN, Medenica S, Racic M, Ristic S, Joksimovic VR, Skipina M.
    Rev Med Chil; 2016 Apr 23; 144(4):434-41. PubMed ID: 27401374
    [Abstract] [Full Text] [Related]

  • 10. A single dose of zafirlukast reduces LTD4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy.
    Smith LJ, Hanby LA, Lavins BJ, Simonson SG.
    Ann Allergy Asthma Immunol; 1998 Jul 23; 81(1):43-9. PubMed ID: 9690572
    [Abstract] [Full Text] [Related]

  • 11. Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist.
    Hui KP, Barnes NC.
    Lancet; 1991 May 04; 337(8749):1062-3. PubMed ID: 1673495
    [Abstract] [Full Text] [Related]

  • 12. The measurement of cough response to bronchoconstriction induced by methacholine inhalation in healthy subjects: An examination using the Astograph method.
    Hara J, Fujimura M, Ohkura N, Sakai T, Yamamura K, Abo M, Koba H, Watanabe S, Yoneda T, Nishikawa S, Sone T, Kimura H, Ishiura Y, Kasahara K.
    Exp Lung Res; 2017 May 04; 43(6-7):240-248. PubMed ID: 28718683
    [Abstract] [Full Text] [Related]

  • 13. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma.
    Sestini P, Armetti L, Gambaro G, Pieroni MG, Refini RM, Sala A, Vaghi A, Folco GC, Bianco S, Robuschi M.
    Am J Respir Crit Care Med; 1996 Feb 04; 153(2):572-5. PubMed ID: 8564100
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion.
    O'Shaughnessy KM, Wellings R, Gillies B, Fuller RW.
    Am Rev Respir Dis; 1993 Jun 04; 147(6 Pt 1):1472-6. PubMed ID: 8389108
    [Abstract] [Full Text] [Related]

  • 15. Inhaled platelet-activating factor increases airway sensitivity but not maximal airway narrowing to methacholine in normal subjects.
    Bellofiore S, Ciancio N, Pennisi A, Coco G, Passanisi G, Ricciardolo FL, Novo S, Di Maria GU.
    Monaldi Arch Chest Dis; 1994 Sep 04; 49(4):288-92. PubMed ID: 8000412
    [Abstract] [Full Text] [Related]

  • 16. Effect of inhaled furosemide on the bronchial response to lysine-aspirin inhalation in asthmatic subjects.
    Vargas FS, Croce M, Teixeira LR, Terra-Filho M, Cukier A, Light RW.
    Chest; 1992 Aug 04; 102(2):408-11. PubMed ID: 1643923
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of allergic bronchoconstriction in asthmatics by the leukotriene-antagonist ICI-204,219.
    Dahlén SE, Dahlén B, Eliasson E, Johansson H, Björck T, Kumlin M, Boo K, Whitney J, Binks S, King B.
    Adv Prostaglandin Thromboxane Leukot Res; 1991 Aug 04; 21A():461-4. PubMed ID: 1847783
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The inhibitory effect of nebulized albuterol on the early and late asthmatic reactions and increase in airway responsiveness provoked by inhaled allergen in asthma.
    Twentyman OP, Finnerty JP, Holgate ST.
    Am Rev Respir Dis; 1991 Oct 04; 144(4):782-7. PubMed ID: 1928949
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.